Presentations

EHA2021 - HALF-LIFE PROLONGATION OF VON WILLEBRAND FACTOR:
A new therapeutic strategy for haemophilia A and von Willebrand Disease

Katarina Kovacevic, PhD, Department of Clinical Pharmacology, Medical University of Vienna, 11.06.2021.